Skip to main content


Mantle Cell Lymphoma

MRD status in peripheral blood or bone marrow prior to autoSCT is an early predictor of PFS and OS in younger patients…
Acalabrutinib is more cost-effective and associated with better clinical outcomes compared with ibrutinib and…
An increase in costs and health care utilization was demonstrated as veteran patients with MCL progressed through…
Back to Top